Response to letter regarding article, "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: The hole truth?"

Stroke

Volumn 44, Issue 2, 2013, Pages

  Thaler, David E ^a   Wahl, Andreas ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; EMBOLISM; HUMAN; LETTER; MEDICAL DEVICE; PATENT FORAMEN OVALE; PATIENT SELECTION; PRIORITY JOURNAL;

FORAMEN OVALE, PATENT; HUMANS; STROKE;

EID: 84872943961     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.680637     Document Type: Letter

References (1)

1. Kent DM, Thaler DE. The Risk of Paradoxical Embolism (Rof Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. 2011;12:185.